Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:48 pm Sale |
2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP |
L1 Capital Global Opportunities Master Fund, Ltd. | 24,736 4.990% |
-9,327 (-27.38%) |
Filing History |
| 2022-02-11 5:48 pm Sale |
2021-12-31 | 13G | GeoVax Labs, Inc. GOVX |
L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% |
-25,597 (Position Closed) |
Filing History |
| 2022-02-11 5:47 pm Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
L1 Capital Global Opportunities Master Fund, Ltd. | 7,000 11.000% |
-59,667 (-89.50%) |
Filing History |
| 2021-12-08 5:00 pm Purchase |
2021-12-07 | 13G | Creative Medical Technology Holdings, Inc. CELZ |
L1 Capital Global Opportunities Master Fund, Ltd. | 32,746 5.100% |
32,746 (New Position) |
Filing History |
| 2021-11-18 4:30 pm Purchase |
2021-07-02 | 13G | Recruiter.com Group, Inc. RCRT |
L1 Capital Global Opportunities Master Fund, Ltd. | 70,195 7.300% |
70,195 (New Position) |
Filing History |
| 2021-03-05 4:13 pm Purchase |
2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX |
L1 Capital Global Opportunities Master Fund, Ltd. | 66,667 16.300% |
66,667 (New Position) |
Filing History |
| 2021-02-09 4:46 pm Sale |
2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
L1 Capital Global Opportunities Master Fund, Ltd. | 42,450 4.800% |
-42,450 (-50.00%) |
Filing History |
| 2021-02-09 4:45 pm Purchase |
2020-12-31 | 13G | Recon Technology, Ltd. RCON |
L1 Capital Global Opportunities Master Fund, Ltd. | 12,222 3.000% |
1,667 (+15.79%) |
Filing History |
| 2021-02-09 4:44 pm Sale |
2020-12-31 | 13G | URBAN TEA INC USD MYT |
L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% |
-6,250,000 (Position Closed) |
Filing History |
| 2021-02-09 4:43 pm Purchase |
2020-12-31 | 13G | Globus Maritime Limited GLBS |
L1 Capital Global Opportunities Master Fund, Ltd. | 158,500 4.800% |
138,149 (+678.82%) |
Filing History |
| 2021-02-09 4:08 pm Sale |
2020-12-31 | 13G | LM Funding America, Inc. LMFA |
L1 Capital Global Opportunities Master Fund, Ltd. | 31,833 3.500% |
-20,433 (-39.09%) |
Filing History |
| 2021-01-25 08:26 am Purchase |
2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP |
L1 Capital Global Opportunities Master Fund, Ltd. | 34,063 6.900% |
17,863 (+110.26%) |
Filing History |
| 2021-01-20 4:05 pm Purchase |
2021-01-12 | 13G | Lexaria Bioscience Corp. LEXX |
L1 Capital Global Opportunities Master Fund, Ltd. | 285,714 5.600% |
285,714 (New Position) |
Filing History |
| 2021-01-19 08:31 am Purchase |
2021-01-06 | 13G | American International Holdings Corp. AMIH |
L1 Capital Global Opportunities Master Fund, Ltd. | 74,583 7.500% |
74,583 (New Position) |
Filing History |
| 2020-11-02 4:10 pm Purchase |
2020-10-22 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
L1 Capital Global Opportunities Master Fund, Ltd. | 84,900 8.600% |
84,900 (New Position) |
Filing History |
| 2020-10-01 4:41 pm Purchase |
2020-09-24 | 13G | Titan Pharmaceuticals, Inc. TTNP |
L1 Capital Global Opportunities Master Fund, Ltd. | 16,200 8.300% |
16,200 (New Position) |
Filing History |
| 2020-09-30 4:05 pm Purchase |
2020-09-25 | 13G | GeoVax Labs, Inc. GOVX |
L1 Capital Global Opportunities Master Fund, Ltd. | 25,597 9.900% |
25,597 (New Position) |
Filing History |
| 2020-08-24 4:26 pm Purchase |
2020-08-14 | 13G | LM Funding America, Inc. LMFA |
L1 Capital Global Opportunities Master Fund, Ltd. | 52,267 9.900% |
52,267 (New Position) |
Filing History |
| 2020-08-19 6:39 pm Purchase |
2020-08-14 | 13G | URBAN TEA INC USD MYT |
L1 Capital Global Opportunities Master Fund, Ltd. | 6,250,000 7.900% |
4,425,007 (+242.47%) |
Filing History |
| 2020-08-19 6:38 pm Sale |
2020-07-31 | 13G | URBAN TEA INC USD MYT |
L1 Capital Global Opportunities Master Fund, Ltd. | 1,824,993 3.000% |
-3,175,007 (-63.50%) |
Filing History |